32. Coronary artery dilatation in Epstein-Barr virus infection: Literature review and a case report in children
Main Article Content
Abstract
Coronary artery dilatation (CAD) is dilatation of the coronary artery lumen that exceeds 1.5 times the diameter of an adjacent normal artery segment due to many causes. Epstein-Barr virus (EBV) is a rare cause of coronary artery dilatation. We report a case of a historically healthy 7-year-old boy who was admitted to the hospital with high fever for 5 days, rash, enlarged lymph nodes, hepatosplenmegaly, pseudomembranous tonsillitis, elevated liver enzymes and dilated left coronary arteries. After excluding Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C), we diagnosed this patient with acute EBV infection and decided to treat with Acyclovir. After treatment, the clinical condition improved and coronary artery diameter returned to normal after 5 weeks. Conclusion: In children infected with EBV, it is necessary to assess coronary artery damage and differential diagnosis with similar diseases for timely treatment.
Article Details
Keywords
Coronary artery dilatation, Epstein-Barr virus (EBV), children
References
2. Ozcan OU, Gulec S. Coronary artery ectasia. Cor et Vasa. 2013;55(3):e242-e247. doi: 10.1016/j.crvasa.2013.01.003.
3. Cohen JI, Jaffe ES, Dale JK, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: A 28-year experience in the United States. Blood. 2011;117(22):5835-5849. doi: 10.1182/blood-2 010-11-316745.
4. Jenson HB. Epstein-Barr virus. Pediatrics In Review. 2011;32(9):375-384. doi: 10.1542/pir.32-9-375.
5. Newburger JW, Burns JC. Kawasaki disease. Vasc Med. 1999;4(3):187-202. doi: 10.1177/1358836X9900400310.
6. Mary Beth F Son, Kevin Friedman. COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis. UpToDate. Accessed June 17, 2022. https://www.medilib.ir/uptodate/show/128190.
7. Kimura H, Ito Y, Suzuki R, Nishiyama Y. Measuring Epstein-Barr virus (EBV) load: The significance and application for each EBV-associated disease. Reviews in Medical Virology. 2008;18(5):305-319. doi: 10.1002/rm v.582.
8. Auwaerter PG. Recent advances in the understanding of infectious mononucleosis: Are prospects improved for treatment or control?. Expert Review of Anti-infective Therapy. 2006;4(6):1039-1049. doi: 10.1586/ 14787210.4.6.1039.
9. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation. 2004;110(17):2747-2771. doi: 10.1161/01.CIR. 0000145143.19711.78.
10. Shu Jiang, Xiao Li, Jian Cao, Di Wu, Lingyan Kong, Lu Lin, Zhengyu Jin, Jing An, Yining Wang. Early diagnosis and follow-up of chronic active Epstein–Barr-virus-associated cardiovascular complications with cardiovascular magnetic resonance imaging. Medicine. 2016;95(31):e4384. doi: 10.1097/M D.0000000000004384.
11. Culora GA, Moore IE. Kawasaki disease, Epstein-Barr virus and coronary artery aneurysms. Journal of Clinical Pathology. 1997;50(2):161-163. doi: 10.1136/jcp.50.2.161.
12. Xiao H, Hu B, Luo R, et al. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis. Virol J. 2020;17:166. doi: 10.1186/s12985-020-014 09-8.
13. Wei A, Ma H, Zhang L, et al. Clinical analysis of chronic active EBV infection with coronary artery dilatation and a matched case-control study. Orphanet Journal of Rare Diseases. 2021;16(1):50. doi: 10.1186/s13023-021-01689-5.
14. Tynell E, Aurelius E, Brandell A, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: A multicenter, double-blind, placebo-controlled study. J Infect Dis. 1996;174(2):324-331. doi: 10.1093/infdis/174.2.324.
15. Wang Q, Morikawa Y, Akahoshi S, et al. Follow-up duration of Echocardiography in patients with Kawasaki disease with no initial coronary aneurysms. The Journal of Pediatrics. 2022;244:133-138.e1. doi: 10.1016/j.jpeds.202 1.11.022.